We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+7.61%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.21B
AUM Growth
+$113M
(+5.4%)
Cap. Flow
-$25.2M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
782
New
22
Increased
58
Reduced
295
Closed
88
Avg Time Held
3.1
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$36.5M |
| 2 |
Arista Networks
ANET
|
+$4.57M |
| 3 |
Donaldson
DCI
|
+$4.43M |
| 4 |
PayPal
PYPL
|
+$4.39M |
| 5 |
Microsoft
MSFT
|
+$3.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$8.9M |
| 2 |
Broadcom
AVGO
|
+$7.18M |
| 3 |
Honeywell
HON
|
+$5.49M |
| 4 |
Essential Utilities
WTRG
|
+$4.55M |
| 5 |
Watsco Inc
WSO
|
+$3.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 13.58% |
| 3 | Miscellaneous | 12.85% |
| 4 | Healthcare | 12.46% |
| 5 | Consumer Discretionary | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
Sylvamo
SLVM
$1.3B
| $1.09K | ﹤0.01% |
27
| – | – |
2021 Q4
6 quarters
|
|
677
Teradata
TDC
$2.82B
| $1.07K | ﹤0.01% |
20
| – | – |
2021 Q4
6 quarters
|
|
|
MGF
678
Aberdeen Government Markets Income Fund
MGF
$87.5M
| $1.03K | ﹤0.01% |
64
| – | – |
2021 Q4
6 quarters
|
|
679
Ceragon Networks
CRNT
$186M
| $897 | ﹤0.01% |
427
| – | – |
2021 Q4
6 quarters
|
|
680
DELISTED
Paramount Global Class B
PARA
| $859 | ﹤0.01% |
54
| – | – |
2021 Q4
6 quarters
|
|
681
Tandem Diabetes Care
TNDM
$1.13B
| $785 | ﹤0.01% |
32
| – | – |
2021 Q4
6 quarters
|
|
682
Kontoor Brands
KTB
$4.01B
| $589 | ﹤0.01% |
14
| – | – |
2021 Q4
6 quarters
|
|
683
NCR Voyix
VYX
$1.05B
| $504 | ﹤0.01% |
33
| – | – |
2021 Q4
6 quarters
|
|
684
Ginkgo Bioworks
DNA
$692M
| $372 | ﹤0.01% |
+5
| New | +$296 |
2023 Q2
0 quarters
|
|
685
Solitario Resources
XPL
$48.8M
| $336 | ﹤0.01% |
584
| – | – |
2021 Q4
6 quarters
|
|
686
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$8.07B
| $309 | ﹤0.01% |
23
| – | – |
2021 Q2
8 quarters
|
|
|
FRC
687
DELISTED
First Republic Bank
FRC
| $266 | ﹤0.01% |
483
| – | – |
2015 Q2
32 quarters
|
|
688
Amarin Corp
AMRN
$239M
| $179 | ﹤0.01% |
8
| – | – |
2021 Q4
6 quarters
|
|
689
FirstEnergy
FE
$26.7B
| $156 | ﹤0.01% |
4
| – | – |
2021 Q4
6 quarters
|
|
690
DELISTED
ZimVie
ZIMV
| $90 | ﹤0.01% |
8
| – | – |
2022 Q2
4 quarters
|
|
691
Abeona Therapeutics
ABEO
$253M
| $52 | ﹤0.01% |
13
| – | – |
2015 Q2
32 quarters
|
|
692
Teladoc Health
TDOC
$1.03B
| $51 | ﹤0.01% |
2
| – | – |
2021 Q4
6 quarters
|
|
|
RAD
693
DELISTED
Rite Aid Corporation
RAD
| $15 | ﹤0.01% |
+10
| New | +$20 |
2023 Q2
0 quarters
|
|
694
Precigen
PGEN
$2.28B
| $3 | ﹤0.01% |
3
| – | – |
2021 Q4
6 quarters
|
|
695
Best Buy
BBY
$19.4B
| – | – |
-400
| Closed | -$31.3K | – |
|
696
Barclays
BCS
$76B
| – | – |
-9
| Closed | -$65 | – |
|
697
Black Hills Corp
BKH
$5.84B
| – | – |
-147
| Closed | -$9.28K | – |
|
698
DELISTED
Brookline Bancorp
BRKL
| – | – |
-5,400
| Closed | -$56.7K | – |
|
699
AB InBev
BUD
$163B
| – | – |
-231
| Closed | -$15.4K | – |
|
700
CDW
CDW
$18.8B
| – | – |
-10
| Closed | -$1.95K | – |
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q2 2023 Portfolio in Review
As of Q2 2023, Cambridge Trust held 782 positions worth $2.21B, up 5.4% from $2.1B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Cambridge Trust's Q2 2023 filing shows 22 new, 58 increased, 295 reduced and 88 closed positions. Its largest new stake was Linde: 99,931 shares worth $38.1M. The largest sale was JPMorgan Chase, an estimated $8.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Miscellaneous.
- Cambridge Trust's largest Q2 2023 buy was Linde: 99,931 shares worth $38.1M.
- Cambridge Trust added most to PayPal in Q2 2023, an estimated $4.39M increase.
- Cambridge Trust's biggest Q2 2023 reduction was JPMorgan Chase, cutting an estimated $8.9M.
- Cambridge Trust fully exited Crane NXT in Q2 2023, selling an estimated $244K.
- Cambridge Trust's ten largest holdings make up 30% of its $2.21B portfolio in Q2 2023.
- Cambridge Trust opened 22 new positions and closed 88 in Q2 2023.
- Cambridge Trust's portfolio value rose 5.4% quarter-over-quarter to $2.21B.
Based on Cambridge Trust's 13F filing for Q2 2023, filed 25 Jul 2023.